Shirley Ferebee Woolpert

United States Public Health Service

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

B Doster

United States Public Health Service

George W. Comstock

Nashville Oncology Associates

Rae Newman

Verna T. Livesay

United States Public Health Service

Francis J. Murray

University of Stirling

Jacqueline Ludford

D Dănkovã

New Bulgarian University

I Vadász

Giessen School of Theology

G W Comstock

OSF St. Joseph Medical Center

Jiří Drápela

Brno University of Technology

Cooperative Institutions

United States Public Health Service

Johns Hopkins University

German Cancer Research Center

New Bulgarian University

University of Rome Tor Vergata

Centre d'études et de recherches internationales de Sciences Po

Charles University

Institut für Lungenforschung

Giessen School of Theology

University of Giessen

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

Ethambutol in the Initial Treatment of Pulmonary Tuberculosis

American Review of Respiratory Disease (2015)

B Doster Francis J. Murray Rae Newman Shirley Ferebee Woolpert

In 4 U. S. Public Health Service trials, ethambutol was tested in doses of 6 and 15 mg per kg as a substitute for p-aminosalicyclic acid in 1,449 patients and as a substitute for pyrazinamide in 326 patients; 1,052 patients treated with nonethambutol regimens served as control subjects. Ethambutol in doses of 15 mg per kg was therapeutically an effective substitute for either p-aminosalicyclic acid or pyrazinamide and was virtually nontoxic. the frequency and degree of changes in visual acuity were equal with ethambutol and nonethambutol regimens.

Pyrazinamide

Source

Cite

Citations (25)

Effect of isoniazid on reproduction.

PubMed (1973)

Jacqueline Ludford B Doster Shirley Ferebee Woolpert

SUMMARY Among persons with fibrotic pulmonary lesions compatible with healed tuberculosis who partici pated in a controlled trial of isoniazid prophylaxis, information was obtained on the living chil dren of 1,165 women and 1,270 men of reproductive age to whom the children were born in the first 5 years of observation. No significant differences were found between the isoniazid and placebo groups in birth rates, sex ratios, or birth weights. Further, women who became pregnant did not develop active tuberculosis more frequently than those who did not have children during the !) years of observations.

Chemoprophylaxis

10.1164/arrd.1973.108.5.1170

Cite

Citations (17)

Effect of Isoniazid on Reproduction1

American Review of Respiratory Disease (2015)

Jacqueline Ludford B Doster Shirley Ferebee Woolpert

Among persons with fibrotic pulmonary lesions compatible with healed tuberculosis who participated in a controlled trial of isoniazid prophylaxis, information was obtained on the living children of...

Source

Cite

Citations (0)

Tuberculosis studies in Muscogee County, Georgia. Twenty-year evaluation of a community trial of BCG vaccination.

PubMed (1976)

George W. Comstock Shirley Ferebee Woolpert Verna T. Livesay

A controlled trial of BCG vaccination was conducted in 1950 in Muscogee County, Ga., and Russell County, Ala. The study population consisted of 64,136 volunteers over the age of 5 years who had satisfactory skin tests with 5 tuberculin units of purified protein derivative and whose chest photofluorograms were considered by two readers to show no significant pulmonary abnormalities. Approximately half of the nonreactors to tuberculin were vaccinated with the Tice strain of BCG by a multiple-puncture method. During a 20-year period of follow-up, 207 cases of tuberculosis were identified among the persons who had been tuberculin reactors in 1950, 36 cases were identified among the controls, and 32 cases were identified among the vaccinees. The average annual case rates per 100,000 were 47.0 for reactors, 13.4 for controls, and 12.6 for vaccinees.

BCG vaccine

Purified protein derivative

Tuberculin test

Source

Cite

Citations (76)

Preventive Treatment of Untreated, Nonactive Tuberculosis in an Eskimo Population

Archives of Environmental Health An International Journal (1972)

George W. Comstock Shirley Ferebee Woolpert

Abstract Twelve years ago, a controlled trial of isonlazid prophylaxis was started in the Bethel area of Alaska. Six years ago, because of its demonstrated effectiveness, isoniazid prophylaxis was offered to the entire population. There were 1,349 persons in the controlled trial who were classified as having untreated, nonactive tuberculosis, and 1,567 such persons in the subsequent demonstration project. Over the six-year period after the controlled trial, persons with untreated, nonactive tuberculosis who took isoniazid well had 71% less tuberculosis than those who took it poorly. Following the subsequent demonstration program, the reduction among those who took isoniazid well was 89%. Preventive treatment of previously untreated, nonactive tuberculosis can make a major contribution to tuberculosis control among populations with a tuberculosis problem similar to that among Alaskan Eskimos.

10.1080/00039896.1972.10666182

Cite

Citations (35)

To the Editor of the American Review of Respiratory Disease

American Review of Respiratory Disease (1972)

Shirley Ferebee Woolpert

"To the Editor of the American Review of Respiratory Disease." American Review of Respiratory Disease, 106(2), pp. 281–282

10.1164/arrd.1972.106.2.281a

Cite

Citations (2)

Evaluation of BCG vaccination among Puerto Rican children.

American Journal of Public Health (1974)

G W Comstock Verna T. Livesay Shirley Ferebee Woolpert

Evaluation of BCG vaccination among Puerto Rican children. G W Comstock, V T Livesay, and S F WoolpertCopyRight https://doi.org/10.2105/AJPH.64.3.283 Published Online: October 07, 2011

Puerto rican

10.2105/ajph.64.3.283

Cite

Citations (89)

Isoniazid prophylaxis among Alaskan Eskimos: a progress report.

PubMed (1974)

G W Comstock Shirley Ferebee Woolpert C Baum

Two isoniazid prophylaxis programs were conducted in the Bethel area of Alaska: a placebo-controlled trial started in 1957, and a community-wide administration of isoniazid in 1964. In both programs, the recommended dose of isoniazid was 4 to 8 mg per kg of body weight taken in a single daily dose for one year. Tuberculosis case rates in the period from 1964 through 1973 indicate that the effectiveness of isoniazid prophylaxis persisted through the fifteenth year after its administration. The results of this and other studies raise the possibility that six months of the standard daily dose of isoniazid may be sufficient for prophylaxis.

10.1164/arrd.1974.110.2.195

Cite

Citations (27)

THE PROGNOSIS OF A POSITIVE TUBERCULIN REACTION IN CHILDHOOD AND ADOLESCENCE

American Journal of Epidemiology (1974)

George W. Comstock Verna T. Livesay Shirley Ferebee Woolpert

Journal Article THE PROGNOSIS OF A POSITIVE TUBERCULIN REACTION IN CHILDHOOD AND ADOLESCENCE Get access GEORGE W. COMSTOCK, GEORGE W. COMSTOCK 1Department of Epidemiology, School of Hygiene and Public Health, Johns Hopkins UniversityBaltimore, Maryland2Research Section, Tuberculosis Branch, Center for Disease ControlBethesda, Maryland Reprint requests to Dr. Comstock, P.O. Box 2067, Hagerstown, Maryland 21740. Search for other works by this author on: Oxford Academic PubMed Google Scholar VERNA T. LIVESAY, VERNA T. LIVESAY 2Research Section, Tuberculosis Branch, Center for Disease ControlBethesda, Maryland Search for other works by this author on: Oxford Academic PubMed Google Scholar SHIRLEY F. WOOLPERT SHIRLEY F. WOOLPERT 2Research Section, Tuberculosis Branch, Center for Disease ControlBethesda, Maryland Search for other works by this author on: Oxford Academic PubMed Google Scholar American Journal of Epidemiology, Volume 99, Issue 2, February 1974, Pages 131–138, https://doi.org/10.1093/oxfordjournals.aje.a121593 Published: 01 February 1974 Article history Received: 30 July 1973 Published: 01 February 1974

George (robot)

10.1093/oxfordjournals.aje.a121593

Cite

Citations (660)

Tuberculin conversions: true or false?

PubMed (1978)

George W. Comstock Shirley Ferebee Woolpert

Tuberculin test

10.1164/arrd.1978.118.2.215

Cite

Citations (26)